✦ LIBER ✦

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer

✍ Scribed by Elise C. Kohn; Gisele A. Sarosy; Patricia Davis; Michaele Christian; Charles E. Link; Frederick P. Ognibene; William F. Sindelar; Joan Jacob; Seth M. Steinberg; Ahalya Premkumar; Eddie Reed

Book ID: 115616915
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 154 KB
Volume: 62
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1996.0213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of dose-intense pacli

A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer: Kohn E.C.; Sarosy G.A.; Davis P.; Christian M.; Link C.E.; Ognibene F.P.; Sindelar W.F.; Jacob J.; Steinberg S.M.; Premkumar A.; Reed E. USA Gynecol Oncol 1996 62/2 (181–191)

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Ten-year follow-up of a phase 2 study of

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer

✍ Gisele A. Sarosy; Mahrukh M. Hussain; Michael V. Seiden; Arlan F. Fuller; Najmos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: The objective of this study was to assess activity and toxicity in patients with newly diagnosed, advanced‐stage epithelial ovarian cancer (EOC) who were receiving dose‐intense paclitaxel, cyclophosphamide, cisplatin, and filgrastim delivered with a flexible dosing sched

Phase I Trial of Carboplatin, Paclitaxel

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

✍ Nadine Tung; Ross Berkowitz; Ursula Matulonis; Marc Quartulli; Michael Seiden; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A Phase II Trial of Intraperitoneal Cisp

A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment

✍ Richard R. Barakat; Lois Almadrones; Ennapadam S. Venkatraman; Carol Aghajanian; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Phase I/II study of concurrent twice-wee

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

✍ Solomon, B.; Ball, D.L.; Richardson, G.; Smith, J.G.; Millward, M.; MacManus, M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB